蛋白质修饰作为乳腺癌潜在的生物标志物
Protein modifications as potential biomarkers in breast cancer.
作者信息
Jin Hongjun, Zangar Richard C
机构信息
Cell Biology and Biochemistry Group, Fundamental and Computational Sciences Directorate, Pacific Northwest National Laboratory, PO Box 999, 902 Battelle Blvd, Richland, WA 99352.
出版信息
Biomark Insights. 2009 Nov 30;4:191-200. doi: 10.4137/bmi.s2557.
Abstract
A variety of post-translational protein modifications (PTMs) are known to be altered as a result of cancer development. Thus, these PTMs are potentially useful biomarkers for breast cancer. Mass spectrometry, antibody microarrays and immunohistochemistry techniques have shown promise for identifying changes in PTMs. In this review, we summarize the current literature on PTMs identified in the plasma and tumor tissue of breast-cancer patients or in breast cell lines. We also discuss some of the analytical techniques currently being used to evaluate PTMs.
摘要
已知多种翻译后蛋白质修饰（PTM）会因癌症发展而发生改变。因此，这些PTM有可能成为乳腺癌的有用生物标志物。质谱分析、抗体微阵列和免疫组织化学技术在识别PTM变化方面已显示出前景。在本综述中，我们总结了目前关于在乳腺癌患者的血浆和肿瘤组织或乳腺细胞系中鉴定出的PTM的文献。我们还讨论了目前用于评估PTM的一些分析技术。
相似文献
1
Protein modifications as potential biomarkers in breast cancer.蛋白质修饰作为乳腺癌潜在的生物标志物
Biomark Insights. 2009 Nov 30;4:191-200. doi: 10.4137/bmi.s2557.
2
The Exposure to Human Breast Cancer Cells Altered 14 Post-Translational Modifications of Human Serum Albumin.暴露于人类乳腺癌细胞会改变人血清白蛋白的14种翻译后修饰。
EJIFCC. 2022 Dec 12;33(4):295-308. eCollection 2022 Dec.
3
Exploring the Role of Unconventional Post-Translational Modifications in Cancer Diagnostics and Therapy.探索非传统翻译后修饰在癌症诊断和治疗中的作用。
Curr Protein Pept Sci. 2024;25(10):780-796. doi: 10.2174/0113892037274615240528113148.
4
Histone proteomics reveals novel post-translational modifications in breast cancer.组蛋白蛋白质组学揭示了乳腺癌中新型的翻译后修饰。
Aging (Albany NY). 2019 Dec 8;11(23):11722-11755. doi: 10.18632/aging.102577.
5
Modifications in the cellular proteome and their clinical application.细胞蛋白质组的修饰及其临床应用。
Medicina (B Aires). 2019;79(Spec 6/1):570-575.
6
Mass spectrometric analysis of high-mobility group proteins and their post-translational modifications in normal and cancerous human breast tissues.正常和癌性人类乳腺组织中高迁移率族蛋白及其翻译后修饰的质谱分析。
J Proteome Res. 2007 Jun;6(6):2304-14. doi: 10.1021/pr070072q. Epub 2007 Apr 25.
7
Dissecting Alzheimer's Disease Molecular Substrates by Proteomics and Discovery of Novel Post-translational Modifications.通过蛋白质组学解析阿尔茨海默病的分子基础及发现新的翻译后修饰。
OMICS. 2019 Jul;23(7):350-361. doi: 10.1089/omi.2019.0085. Epub 2019 Jun 21.
8
Post-translational quantitation by SRM/MRM: applications in cardiology.通过SRM/MRM进行翻译后定量分析：在心脏病学中的应用
Expert Rev Proteomics. 2018 Jun;15(6):477-502. doi: 10.1080/14789450.2018.1484283.
9
Characterizing disease-associated changes in post-translational modifications by mass spectrometry.通过质谱法描绘翻译后修饰中的疾病相关变化。
Expert Rev Proteomics. 2018 Mar;15(3):245-258. doi: 10.1080/14789450.2018.1433036. Epub 2018 Feb 1.
10
SILAC-based proteomic analysis to dissect the "histone modification signature" of human breast cancer cells.基于 SILAC 的蛋白质组学分析解析人类乳腺癌细胞的“组蛋白修饰特征”。
Amino Acids. 2011 Jul;41(2):387-99. doi: 10.1007/s00726-010-0668-2. Epub 2010 Jul 9.
引用本文的文献
1
Deciphering a proteomic signature for the early detection of breast cancer from breast milk: the role of quantitative proteomics.从母乳中破译用于早期检测乳腺癌的蛋白质组学特征：定量蛋白质组学的作用。
Expert Rev Proteomics. 2024 Jan-Mar;21(1-3):81-98. doi: 10.1080/14789450.2024.2320158. Epub 2024 Feb 23.
2
XGDAG: explainable gene-disease associations via graph neural networks.XGDAG：通过图神经网络进行可解释的基因-疾病关联
Bioinformatics. 2023 Aug 1;39(8). doi: 10.1093/bioinformatics/btad482.
3
Spatial Proteomics for the Molecular Characterization of Breast Cancer.用于乳腺癌分子特征分析的空间蛋白质组学
Proteomes. 2023 May 3;11(2):17. doi: 10.3390/proteomes11020017.
4
Studying protein structure and function by native separation-mass spectrometry.通过天然分离质谱法研究蛋白质结构与功能。
Nat Rev Chem. 2022 Mar;6(3):215-231. doi: 10.1038/s41570-021-00353-7. Epub 2022 Jan 20.
5
Lysine Malonylation and Its Links to Metabolism and Diseases.赖氨酸丙二酰化及其与代谢和疾病的关联。
Aging Dis. 2023 Feb 1;14(1):84-98. doi: 10.14336/AD.2022.0711.
6
Proteomics-Based Identification of Dysregulated Proteins in Breast Cancer.基于蛋白质组学的乳腺癌中失调蛋白的鉴定
Proteomes. 2022 Oct 21;10(4):35. doi: 10.3390/proteomes10040035.
7
Glycyrrhizic Acid Inhibits Core Fucosylation Modification Modulated EMT and Attenuates Bleomycin-Induced Pulmonary Fibrosis.甘草酸抑制核心岩藻糖基化修饰介导的上皮-间质转化并减轻博来霉素诱导的肺纤维化。
Evid Based Complement Alternat Med. 2022 Jul 6;2022:5943322. doi: 10.1155/2022/5943322. eCollection 2022.
8
Ferrochelatase: Mapping the Intersection of Iron and Porphyrin Metabolism in the Mitochondria.亚铁螯合酶：定位线粒体中铁与卟啉代谢的交叉点
Front Cell Dev Biol. 2022 May 12;10:894591. doi: 10.3389/fcell.2022.894591. eCollection 2022.
9
Dance of The Golgi: Understanding Golgi Dynamics in Cancer Metastasis.高尔基的舞蹈：解析高尔基在癌症转移中的动力学
Cells. 2022 Apr 28;11(9):1484. doi: 10.3390/cells11091484.
10
Proteomics and its applications in breast cancer.蛋白质组学及其在乳腺癌中的应用。
Am J Cancer Res. 2021 Sep 15;11(9):4006-4049. eCollection 2021.
本文引用的文献
1
Enhanced immune recognition of cryptic glycan markers in human tumors.增强对人类肿瘤中隐蔽聚糖标志物的免疫识别。
Cancer Res. 2009 Mar 1;69(5):2018-25. doi: 10.1158/0008-5472.CAN-08-3589. Epub 2009 Feb 17.
2
An integrated top-down and bottom-up strategy for broadly characterizing protein isoforms and modifications.一种用于全面表征蛋白质异构体和修饰的自上而下与自下而上相结合的策略。
J Proteome Res. 2009 Mar;8(3):1347-57. doi: 10.1021/pr800720d.
3
Unraveling the S-nitrosoproteome: tools and strategies.解析S-亚硝基化蛋白质组：工具与策略
Proteomics. 2009 Feb;9(4):808-18. doi: 10.1002/pmic.200800546.
4
Specific activity of class II histone deacetylases in human breast cancer cells.人类乳腺癌细胞中II类组蛋白去乙酰化酶的比活性。
Mol Cancer Res. 2008 Dec;6(12):1908-19. doi: 10.1158/1541-7786.MCR-08-0299.
5
Pancreatic cancer serum detection using a lectin/glyco-antibody array method.使用凝集素/糖抗体阵列法检测胰腺癌血清
J Proteome Res. 2009 Feb;8(2):483-92. doi: 10.1021/pr8007013.
6
Cytoplasmic CXCR4 expression in breast cancer: induction by nitric oxide and correlation with lymph node metastasis and poor prognosis.乳腺癌中细胞质CXCR4的表达：一氧化氮的诱导作用及其与淋巴结转移和预后不良的相关性
BMC Cancer. 2008 Nov 23;8:340. doi: 10.1186/1471-2407-8-340.
7
Systematic mapping of posttranslational modifications in human estrogen receptor-alpha with emphasis on novel phosphorylation sites.人类雌激素受体α翻译后修饰的系统图谱绘制，重点关注新的磷酸化位点。
Mol Cell Proteomics. 2009 Mar;8(3):467-80. doi: 10.1074/mcp.M800282-MCP200. Epub 2008 Nov 3.
8
Is Sialyl Lewis x antigen expression a prognostic factor in patients with breast cancer?唾液酸化路易斯x抗原表达是否为乳腺癌患者的预后因素？
Int J Surg Pathol. 2008 Oct;16(4):365-74. doi: 10.1177/1066896908324668.
9
Application of electron transfer dissociation (ETD) for the analysis of posttranslational modifications.电子转移解离（ETD）在翻译后修饰分析中的应用。
Proteomics. 2008 Nov;8(21):4466-83. doi: 10.1002/pmic.200800329.
10
Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer.用于通过免疫组织化学定量评估核蛋白表达的新型图像分析方法：在乳腺癌雌激素和孕激素受体水平测量中的应用。
Breast Cancer Res. 2008;10(5):R89. doi: 10.1186/bcr2187. Epub 2008 Oct 23.
Zotero 插件